Novartis Pharmaceuticals Corporation 2022-06-15 Health moderate FDA
Health · FDA · Recall #FDA-D-0985-2022
Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5… Recall
Issued June 15, 2022 · Novartis Pharmaceuticals Corporation
In June 2022, Novartis Pharmaceuticals Corporation recalled the Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications.
What you should do
- 1 Stop using Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Novartis Pharmaceuticals Corporation to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Novartis Pharmaceuticals Corporation
- Category
- Health
- Recall date
- June 15, 2022
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0985-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Novartis Pharmaceuticals Corporation has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.